Cancer of the Pancreas—Actual 5, 10, and 20+Year Survival: The Lucky and Fortunate Few

Avram M. Cooperman, Howard Bruckner, Harry Snady, Hillel Hammerman, Andrew Fader, Michael Feld, Frank Golier, Tom Rush, Jerome Siegal, Franklin Kasmin, Seth Cohen, Michael G. Wayne, Mazen E. Iskandar, Justin G. Steele

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations

Abstract

Cancer of the pancreas (CaP) is a dismal, uncommon, systemic malignancy. This article updates an earlier experience of actual long-term survival of CaP in patients treated between 1991 to 2000, and reviews the literature. Survival is expressed as actual, not projected, survival.

Original languageEnglish
Pages (from-to)73-85
Number of pages13
JournalSurgical Clinics of North America
Volume98
Issue number1
DOIs
StatePublished - Feb 2018
Externally publishedYes

Keywords

  • 5Fluorouracil, Streptozotocin, Cis-Platinum (FSP)
  • Actual vs actuarial survival
  • Cancer of the pancreas (CaP)
  • Chemoradiation therapy (CRT)
  • Lead time bias, Selection bias, Length bias
  • Pancreaticoduodenal resection (PDR)

Fingerprint

Dive into the research topics of 'Cancer of the Pancreas—Actual 5, 10, and 20+Year Survival: The Lucky and Fortunate Few'. Together they form a unique fingerprint.

Cite this